The Goldman Guide

Launched in May 2010, The Goldman Guide is a free weekly publication of Goldman Small Cap Research and is written by Founder Rob Goldman with contributions from the GSCR contributor team. This non-sponsored investment newsletter seeks to provide investors with market, economic, political and equity-specific insights via an action-oriented, straight to the point approach. No companies mentioned in this newsletter are current sponsored research clients of the Company or its parent, With rare exceptions, all companies or investment ideas mentioned in this publication are publicly traded stocks listed either on the NYSE or the NASDAQ.



Our Top Short Term Trades
Written by Rob Goldman   

By now, most of you have heard the terrible news regarding the Malaysian airliner that disappeared over the weekend. It is believed that with some passengers carrying false passports on board it may have been the target of a terrorist attack, or perhaps was shot down by a missile.

I have followed security and bomb detection companies on and off for 20 years and anytime a perceived or real aviation attack occurs, explosive detection system companies rally for at least a couple of days. With that in mind, in this week’s The Goldman Guide there are 3 stocks to buy including stock that trades under $1.

Read more...
 
Shorts Are Nothing But Deceivers
Written by Rob Goldman   

Today’s edition of The Goldman Guide is the most important piece we have written in four years for anyone that is long small cap stocks.

Not only do I encourage you to read this piece in its entirety but I highly recommend you forward this to anyone you know that invests in small stocks. Tweet about it. Post it on message boards. The word needs to get out:

Short sellers are nothing but deceivers and you can make money at their expense. Do not fear them.

Read more...
 
Questions to Ask Before Buying
Written by Rob Goldman   

Today’s edition of The Goldman Guide notes that while we believe the risk is greater that the market will drop than rise, there are obvious sectors that could have a strong March. Separately, there is one sector in particular that will likely be the beneficiary of a migration out of consumer stocks. Finally, we demonstrate that a bunch of IPOs and questionable M&A like the Facebook deal are signals that the bull market is in the latter innings of its run.

Read more...
 
Stocks Up, But Market Down?
Written by Rob Goldman   

While the broader market rose last week, small stocks lagged and declined for the week. We expect this trend to continue and that is not good news. What is really striking is the fact that based on news stories late in the week regarding Sony (NYSE – SNE) and Apple (NASDAQ – AAPL). We are truly concerned that we are seeing early signs of the next consumer technology meltdown.

Read more...
 
Subtle Doomsday Signs for Tech Stocks?
Written by Rob Goldman   

While the broader market rose last week, small stocks lagged and declined for the week. We expect this trend to continue and that is not good news. What is really striking is the fact that based on news stories late in the week regarding Sony (NYSE – SNE) and Apple (NASDAQ – AAPL). We are truly concerned that we are seeing early signs of the next consumer technology meltdown.

Read more...
 
Best Performer Reaching New Highs
Written by Rob Goldman   

Goodbye January and good riddance! Wow that was ugly. Instead of re-hashing all of the things you have heard or read, there are some major trends occurring under the radar that will require you to put certain stocks on your trading list. We have been all over the trends of late, calling them perfectly I am proud to say. For example, Plandai (OTCQB – PLPL)) might be the best performer of the year, reaching $2.99 on Friday after ending the year around $0.45 – 0.50.  It has become the proxy for medical marijuana. Also, last week we recommended a play on Valentine’s Day that rose nicely (1-800-Flowers – NASDAQ - FLWS) despite the big market drops.

In addition to the continuation of the marijuana stock upward trends this week, see why these two eyeglass makers are poised to rock and why this wine stock will run dry. The trends are undeniable and the market has not yet priced them into the shares just yet, presenting a great opportunity to take advantage of investors’ falling asleep at the switch.

Read more...
 
This Stock Jumps Every Year
Written by Rob Goldman   

There is no other way of saying it. The market is ugly. We called it two weeks ago but through it might not happen until this week. Alas, we at least may get a strong sense of what lies ahead for the rest of the quarter, by simply looking at the calendar. Read on to see how the calendar could answer many of our questions about what your investments will look like a few months from now.

In addition to the big picture, we have identified 1 retail stock to buy that has jumped every year for 3 straight years, in the weeks before Valentine’s Day. Plus, here are 2 stocks to sell including one that is the source of a recent tragedy. Frankly, it might be a good short as the Street may not wise up as to its problems for a while.

Read more...
 
The Marijuana Bowl
Written by Rob Goldman   

In today’s edition of The Goldman Guide we have 4 important points of interest:

  1. See why what we call The Marijuana Bowl, otherwise known as the upcoming Super Bowl will have some investors that follow The Super Bowl Indicator for stocks, spooked. Plus, see why the news really isn’t all bad, if you just lift up the hood and look at the indicator’s numbers.
  2. President Obama said that marijuana is not as dangerous as alcohol and clearly all medical marijuana companies are loving life as a result. This sector and stocks related to it are thus primed to remain high for a while, especially given the Super Bowl’s participants and the heavy dose of marijuana press that will result from it.
  3. There are 5 reasons to buy NASDAQ-listed RMCF which is a combination of a valuation, Valentine’s Day, marijuana, dividend, and earnings announcement play. FYI, our pick last week quickly rose 19% and RMCF could see similar returns over the next few weeks.
  4. Finally, we are introducing a new, unnamed mystery contributor sure to make you laugh or scream.
Read more...
 
What the Market is Telling You to Buy
Written by Rob Goldman   

We are two weeks into the New Year and with few exceptions the market appears to be directionless. Overall volume is not really a concern but a poor start to the early earnings season or reduced expectations could crack the fragile state of stocks. See why the market is telling you to avoid retail stock at all costs and why speculators are all over the biotech space right now. Nonetheless, the current macro and market situation tell us why tech stocks are the place to be. To make due diligence easier, we highlight a sub-$5 NASDAQ – listed tech stock that made a big move last week but is set to keep on truckin’.

Read more...
 
These Stocks Should Reach New Highs
Written by Rob Goldman   

Some investors are already fretting about the stock market’s direction. We are not concerned and you should not be, either. After all, our industry themes such s 2013 stocks out of favor, health care plays and industrials are making moves higher.

Looking to generate string January returns? Today, we highlight 3 unique plays to accomplish this objective.

  1. A tech play where the CEO bought $2.5M worth of shares 10 days ago at a price 16% higher.  Buying such a large amount at year-end is a great indicator of the stock’s real value and readers would be wise to consider it.
  2. One niche, nascent industry is under big accumulation and it looks like it finally has some legs. Stocks in the space carry great risk but could offer great short term rewards.
  3. This industrial stock has traded higher on huge volume, reached a new high, but still trades at a pittance, compared to its price/revenue multiple.
Read more...
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 15 of 27